Jiangsu Hengrui Medicine Co.,Ltd.’s Net Profit Dropped 1.2% in First Three Quarters of 2021

Jiangsu Hengrui Medicine Co.,Ltd. (江苏恒瑞医药股份有限公司) (600276.SH) reported a net profit of 4.2 billion yuan in the first three quarters of 2021, down 1.2% year-on-year.

Meanwhile, the company posted 20.2 billion yuan in revenue, up 4% year-on-year.

At the end of the reporting period, it had 39 billion yuan in total assets and 4.1 billion yuan in total liabilities, with a liability-to-asset ratio of 10.6%.

This article was automatically produced by Caixin Automation on Nov. 3, 2021.

Download our app to receive breaking news alerts and read the news on the go.

Follow the Chinese markets in real time with Caixin Global’s new stock database.